Cadila Healthcare Ltd has received tentative approval from US FDA to market its antibiotic, Gatifloxacin tablets, 200 mg and 400 mg, in the US market. The company would market the broad-spectrum......
The Union Health Ministry may ban two drugs, Gatifloxacin and Tegaserod, soon. Gatifloxacin is an antibiotic and Tegaserod is meant to treat irritable bowel syndrome.The move comes after......